Gossamer Bio
GOSS· Manufacturing· Fiscal year ends in December
Faheem Hasnain is the CEO of Gossamer Bio and was paid $2.3M in FY2025 (Dec), up 15%.
Executives3
See all- 1Faheem HasnainChairman, President and Chief Executive OfficerFY2025
- 2Bryan GiraudoChief Operating Officer and Financial OfficerFY2025
- 3Robert SmithChief Commercial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allGossamer Bio paid its 3 named executives $4.7M in total in FY2025 (Dec). CEO Faheem Hasnain was paid $2.3M of that.
| Name | |||
|---|---|---|---|
| Faheem HasnainChairman, President and Chief Executive Officer | |||
| Bryan GiraudoChief Operating Officer and Financial Officer | |||
| Robert SmithChief Commercial Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers19
See allThe FY2025 (Dec) proxy of Gossamer Bio names 19 peer companies for pay. Among Gossamer Bio and these peers, CEO pay was the lowest of 7 and total shareholder return was 4th highest of 7.
7th highest of 7in Gossamer Bio and its pay peers, FY2025 (Dec) by CEO pay:
4th highest of 7in Gossamer Bio and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board2
See all- Russell CoxDirector · 7 yr on the boardIndependentAudit, Compensation (Chair)—Paid as an executive
- Skye DrynanDirector · 1 yr on the boardIndependentAudit (Chair)—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 24, 2026 | FY2025 |
| Annual report | 10-K | Mar 17, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 29, 2025 | FY2024 |
| Annual report | 10-K | Mar 13, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 24, 2024 | FY2023 |
| Annual report | 10-K | Mar 5, 2024 | FY2023 |
